ストックスクリーナーアプリを入手
11.21
2.56%
0.28
プレマーケット:
10.93
-0.28
-2.50%
前日終値:
$10.93
開ける：
$10.97
24時間の取引高:
186.57K
Relative Volume:
0.71
時価総額：
$416.22M
収益：
-
当期純損益:
$-63.78M
株価収益率:
-4.1828
EPS:
-2.68
ネットキャッシュフロー:
$-53.91M
1週間 パフォーマンス:
+6.46%
1か月 パフォーマンス:
-10.03%
6か月 パフォーマンス:
-35.13%
1年 パフォーマンス:
-24.05%
1日の値動き範囲:
$10.84
$11.36
1週間の範囲:
$10.56
$11.69
52週間の値動き範囲:
$10.35
$22.19
Celcuity Inc Stock (CELC) Company Profile
CELC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CELC
Celcuity Inc
|
11.21 | 416.22M | 0 | -63.78M | -53.91M | -2.68 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Celcuity Inc Stock (CELC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-07-22 | 開始されました | Leerink Partners | Outperform |
| 2024-02-22 | 開始されました | Stifel | Buy |
| 2023-12-08 | 開始されました | H.C. Wainwright | Buy |
| 2021-10-08 | 開始されました | Canaccord Genuity | Buy |
| 2021-09-07 | 開始されました | Jefferies | Buy |
| 2021-07-29 | 開始されました | Cowen | Outperform |
| 2021-07-27 | 開始されました | Needham | Buy |
| 2021-01-28 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-12-24 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-05-11 | 再開されました | Craig Hallum | Buy |
| 2018-11-20 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Celcuity Inc (CELC) 最新ニュース
Hennion & Walsh Asset Management Inc. Buys 71,006 Shares of Celcuity Inc. (NASDAQ:CELC) - MarketBeat
Celcuity Inc. (NASDAQ:CELC) Receives $29.17 Average PT from Analysts - Defense World
Celcuity Inc. (NASDAQ:CELC) Holdings Raised by Barclays PLC - Defense World
Celcuity Inc. (NASDAQ:CELC) Shares Bought by Barclays PLC - MarketBeat
Celcuity Inc. (NASDAQ:CELC) Receives $29.17 Average PT from Brokerages - MarketBeat
Analyzing Celcuity (NASDAQ:CELC) and CannLabs (OTCMKTS:CANL) - Defense World
Jane Street Group LLC Sells 9,921 Shares of Celcuity Inc. (NASDAQ:CELC) - Defense World
Celcuity stock touches 52-week low at $11.51 amid market challenges - Investing.com India
Objective long/short (CELC) Report - Stock Traders Daily
Geode Capital Management LLC Acquires 136,518 Shares of Celcuity Inc. (NASDAQ:CELC) - MarketBeat
Celcuity Inc. (NASDAQ:CELC) Shares Purchased by Geode Capital Management LLC - Defense World
Celcuity Inc. (NASDAQ:CELC) Shares Acquired by Barclays PLC - Defense World
Barclays PLC Raises Stock Position in Celcuity Inc. (NASDAQ:CELC) - MarketBeat
Celcuity (NASDAQ:CELC) Trading Up 3.8%Here's Why - MarketBeat
State Street Corp Purchases 668,318 Shares of Celcuity Inc. (NASDAQ:CELC) - MarketBeat
How to Take Advantage of moves in (CELC) - Stock Traders Daily
Celcuity Inc. (NASDAQ:CELC) Receives $29.17 Consensus Target Price from Analysts - Defense World
Celcuity Inc. (NASDAQ:CELC) Given Average Rating of "Buy" by Analysts - MarketBeat
Wellington Management Group LLP Makes New Investment in Celcuity Inc. (NASDAQ:CELC) - MarketBeat
Mama's Creations Posts Weak Earnings, Joins EVgo, Red Cat Holdings And Other Big Stocks Moving Lower In Tuesday's Pre-Market SessionCelcuity (NASDAQ:CELC), Apellis Pharmaceuticals (NASDAQ:APLS) - Benzinga
Celcuity (CELC) Charges Forward with Promising Potential Cancer Treatments - TipRanks
Celcuity Inc. (NASDAQ:CELC) Short Interest Update - MarketBeat
Charles Schwab Investment Management Inc. Purchases 153,712 Shares of Celcuity Inc. (NASDAQ:CELC) - Defense World
(CELC) Investment Report - Stock Traders Daily
BNP Paribas Financial Markets Raises Holdings in Celcuity Inc. (NASDAQ:CELC) - MarketBeat
BNP Paribas Financial Markets Has $673,000 Stake in Celcuity Inc. (NASDAQ:CELC) - Defense World
Celcuity reports survival data for breast cancer drug - Investing.com
Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in Combination with Palbociclib and Endocrine Therapy at the 2024 San Antonio Breast Cancer Symposium - The Manila Times
Celcuity Presents Overall Survival Data from Phase 1b Study - GlobeNewswire
Verition Fund Management LLC Reduces Holdings in Celcuity Inc. (NASDAQ:CELC) - MarketBeat
Celcuity's Breast Cancer Drug Shows Breakthrough 77-Month Survival Data in Clinical Trial - StockTitan
Braidwell LP Buys 367,663 Shares of Celcuity Inc. (NASDAQ:CELC) - MarketBeat
Celcuity Inc. (NASDAQ:CELC) Given Consensus Rating of "Buy" by Brokerages - MarketBeat
(CELC) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Celcuity’s (CELC) “Buy” Rating Reiterated at Needham & Company LLC - Defense World
Celcuity’s (CELC) “Buy” Rating Reiterated at HC Wainwright - Defense World
Celcuity (NASDAQ:CELC) Receives "Buy" Rating from HC Wainwright - MarketBeat
Celcuity stock hits 52-week low at $12.14 amid market shifts - Investing.com
500: Something went wrong - Investing.com India
Earnings call: Celcuity reports Q3 2024 financials and clinical trial updates - Investing.com
Celcuity's (CELC) Buy Rating Reaffirmed at Needham & Company LLC - MarketBeat
Celcuity Inc. (NASDAQ:CELC) Q3 2024 Earnings Call Transcript - Insider Monkey
RA Capital Management, L.P. Acquires New Stake in Celcuity Inc - GuruFocus.com
Celcuity Inc (CELC) Q3 2024 Earnings Call Highlights: Clinical Milestones and Financial Challenges By GuruFocus - Investing.com Canada
COMMODORE CAPITAL LP's Strategic Acquisition of Celcuity Inc Sha - GuruFocus.com
Celcuity Inc. Reports Q3 Progress and Financials - TipRanks
Celcuity Inc. Reports Third Quarter Financial Results and Provides Corporate Update - The Manila Times
Celcuity CEO to Present at Stifel and Jefferies Healthcare Conferences This Month | CELC Stock News - StockTitan
Celcuity Inc. To Present at Upcoming Stifel and Jefferies Investor Conferences - GlobeNewswire
Long Term Trading Analysis for (CELC) - Stock Traders Daily
Celcuity (CELC) Scheduled to Post Earnings on Thursday - MarketBeat
Celcuity Inc (CELC) 財務データ
収益
当期純利益
現金流量
EPS
4.81%
大文字化:
|
ボリューム (24 時間):